Plain-English translation of NCT07358754 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Fibromyalgia causes widespread pain, fatigue, and sleep problems that are hard to treat. This study is looking at two specific substances in the blood—S100B and brain-derived neurotrophic factor (BDNF)—to see if they're connected to the pain sensitivity and sleep trouble that people with fibromyalgia experience. By comparing blood samples from women with fibromyalgia to healthy women without the condition, researchers hope to understand the biological causes of fibromyalgia better.
Doctors still don't fully understand why fibromyalgia happens or what makes the nervous system more sensitive to pain in these patients. This research could help identify biological markers that explain central sensitization—the overactive pain response—and poor sleep, which might eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
You will come in for a single visit where you'll have a blood sample taken and complete several questionnaires about your pain, sleep quality, mood, and how fibromyalgia affects your daily life. The whole visit takes a few hours, and there are no follow-up appointments or ongoing treatment. The study is observational, meaning the researchers are only measuring and comparing, not testing a new medication or therapy.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Turkey (Türkiye)